R. Jenni

Discipline

Psychologie (12)

Type de document

Articles (19) Colloques et conférences (1)

Co-auteur

Date

Source

Mot-clé

Patients (18) Patients (18) Psychoses (17) Schizophrenia (15) Human beings (13) Oxidative stress (13) adulte (11) adulte (11) Treatment (10) Brain (10) cerveau (10) Symptoms (9) Glutathione (9) jeune (8) traitement (7) Processing (7) Months (6) temps (durée) (5) thérapie (5) oxydoréduction (5) modèle (5) Time (5) Therapeutics (5) Example (5) Biochemical markers (5) maladie (5) stratification (4) vitesse (4) risque (4) association (4)

Documents écrit par R. Jenni (19) | parle de R. Jenni (0)

Characterization of early psychosis patients carrying a genetic vulnerability to redox dysregulation: a computational analysis of mechanism-based gene expression profile in fibroblasts.
B. Giangreco et al.
Time of exposure to social defeat stress during childhood and adolescence and redox dysregulation on long-lasting behavioral changes, a translational study.
M. Schnider et al. (26 sept. 2022)
Interaction Testing and Polygenic Risk Scoring to Estimate the Association of Common Genetic Variants With Treatment Resistance in Schizophrenia.
A.F. Pardiñas et al. (1 mars 2022)
Mitochondrial, exosomal miR137-COX6A2 and gamma synchrony as biomarkers of parvalbumin interneurons, psychopathology, and neurocognition in schizophrenia.
I. Khadimallah et al.
Bridging structural MRI with cognitive function for individual level classification of early psychosis via deep learning.
Y. Wen et al. (2022)
Six months functional response to early psychosis intervention program best predicts outcome after three years.
P. Golay et al.
Timely N-Acetyl-Cysteine and Environmental Enrichment Rescue Oxidative Stress-Induced Parvalbumin Interneuron Impairments via MMP9/RAGE Pathway: A Translational Approach for Early Intervention in Psychosis.
D. Dwir et al. (21 oct. 2021)
Topology predicts long-term functional outcome in early psychosis.
M. Fournier et al.
MMP9/RAGE pathway overactivation mediates redox dysregulation and neuroinflammation, leading to inhibitory/excitatory imbalance: a reverse translation study in schizophrenia patients.
D. Dwir et al.
N-Acetyl-Cysteine Supplementation Improves Functional Connectivity Within the Cingulate Cortex in Early Psychosis: A Pilot Study.
E. Mullier et al. (1 août 2019)
Brain connectivity alterations in early psychosis: from clinical to neuroimaging staging.
A. Griffa et al. (4 févr. 2019)
Redox dysregulation as a link between childhood trauma and psychopathological and neurocognitive profile in patients with early psychosis.
L. Alameda et al. (4 déc. 2018)
Patients participating to neurobiological research in early psychosis: A selected subgroup?
P. Golay et al.
N-acetylcysteine add-on treatment leads to an improvement of fornix white matter integrity in early psychosis: a double-blind randomized placebo-controlled trial.
P. Klauser et al. (12 oct. 2018)
N-acetylcysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.
P. Conus et al. (15 févr. 2018)
Treatment in early psychosis with N-acetyl-cysteine for 6 months improves low-level auditory processing: Pilot study.
C. Retsa et al.
The coupling of low-level auditory dysfunction and oxidative stress in psychosis patients.
E. Geiser et al.
Genetic Polymorphism Associated Prefrontal Glutathione and Its Coupling With Brain Glutamate and Peripheral Redox Status in Early Psychosis.
L. Xin et al.
Frontal cortical thickness correlates positively with impulsivity in early psychosis patients
P. S. Baumann et al.